Partnering refers to the process of enabling one or more services to provide secure communication and collaboration between the Company and its external business partners.
EngageZone provides a secure and highly compartmentalized collaborative work environment for the Company and its worldwide business partners to exchange documents and to facilitate communications. Partners signing into EngageZone have controlled access and visibility to all their collaborations that use EngageZone in one place, regardless of which company business units they are working with. Merck is known as MSD outside the United States and Canada.
Our clinical trials are designed, conducted and monitored in adherence to the same standards, whether they take place in the United States or elsewhere around the world. In conducting clinical trials, we also adhere to the guidelines of The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
The Company-sponsored clinical trials in patients are registered on ClinicalTrials.gov, a service of the U.S. National Institutes of Health. Links to the Company's sponsored clinical trials by phase are found in Explore our Pipeline. Information about ongoing clinical trials is also available online through the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). Merck is known as MSD outside the United States and Canada.
Interested in Conducting Company Clinical Trials?
Submit your profile to become a potential Clinical Trial Investigator for a Company Clinical Trial. (US physicians only at this time)
The Investigator Initiated Studies (IIS) Program consists of committees of medical and scientific staff from different therapeutic areas who meet to review investigator study proposals. Use this link if you are interested in learning more about the IIS Program. Merck is known as MSD outside the United States and Canada.
For all the original research we conduct, we know that the next great discovery in medicine may come from outside of our laboratories. This is why the formation of strategic partnerships is a central part of our mission to turn breakthrough science into novel medicines that improve patients' lives.
Flexibility, innovation and creativity are at the heart of the way we work with partners around the world. Our MRL scientists and licensing team works with partners to advance their science through drug discovery and development collaborations and licensing agreements that are mutually beneficial. Merck is known as MSD outside the United States and Canada.